Armata Pharmaceuticals (ARMP) Total Liabilities (2013 - 2026)
Armata Pharmaceuticals (ARMP) posted Total Liabilities of $381.4 million for Q1 2026, up 29.07% sequentially from $295.5 million in Q4 2025, and up 170.42% YoY from $141.0 million in Q1 2025.
Armata Pharmaceuticals (ARMP) Total Liabilities (2013 - 2026) Analysis & Trends
Armata Pharmaceuticals has reported Total Liabilities for 14 years, with the latest figure at $381.4 million in Q1 2026.
- Quarterly Total Liabilities rose 170.42% year-over-year to $381.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $381.4 million (up 170.42% YoY) and the FY2025 annual result came in at $295.5 million, up 119.76% from the prior year.
- Total Liabilities grew to $381.4 million in Q1 2026 per ARMP's latest filing, from $295.5 million in the prior quarter.
- Over five years, Total Liabilities peaked at $381.4 million in Q1 2026 and troughed at $46.2 million in Q1 2022.
- A 5-year average of $140.8 million and a median of $134.5 million in 2024 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2025 and 2026: Total Liabilities retreated 20.26% in 2025, then jumped 170.42% in 2026.
- Over 5 years, Total Liabilities stood at $59.8 million in 2022, then surged by 118.27% to $130.4 million in 2023, then grew by 3.09% to $134.5 million in 2024, then soared by 119.76% to $295.5 million in 2025, then increased by 29.07% to $381.4 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $381.4 million, $295.5 million, and $185.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.70 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 65.23 Bn | 60.05 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 60.16 Bn | 55.02 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.86 Bn | 28.55 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.24 Bn | 9.85 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 10.03 Bn |
| 10 | Armata Pharmaceuticals | 177.86 Mn | 153.86 Mn | - | 321.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 321.12 Mn |
| Mar 31, 2026 | 381.39 Mn |
| Dec 31, 2025 | 295.48 Mn |
| Sep 30, 2025 | 185.10 Mn |
| Jun 30, 2025 | 150.29 Mn |
| Mar 31, 2025 | 141.03 Mn |
| Dec 31, 2024 | 134.46 Mn |
| Sep 30, 2024 | 149.21 Mn |
| Jun 30, 2024 | 154.41 Mn |
| Mar 31, 2024 | 176.87 Mn |
| Dec 31, 2023 | 130.43 Mn |
| Sep 30, 2023 | 125.15 Mn |
| Jun 30, 2023 | 82.07 Mn |
| Mar 31, 2023 | 86.33 Mn |
| Dec 31, 2022 | 59.75 Mn |
| Sep 30, 2022 | 47.30 Mn |
| Jun 30, 2022 | 47.69 Mn |
| Mar 31, 2022 | 46.23 Mn |
| Dec 31, 2021 | 44.37 Mn |
| Sep 30, 2021 | 18.92 Mn |